Antipodes shuns 'expensive defensive' in favour of pharma and Chinese consumer stocks
Backs China vs US post-recovery
CIO of Antipodes Jacob Mitchell
Australian asset management firm Antipodes has used the equity market sell-off to target undervalued "defensive" parts of the pharmaceutical sector, as well as opportunities arising from the Chinese consumer as the country's lockdown begins to be phased out.
Founder and CIO of the $6bn AUM firm Jacob Mitchell (pictured) said he remains cautious of "expensive defensive" parts of the market, which have performed strongly so far in this crisis as they will "ultimately...
More on Equities
Back to Top
